Near‐Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti‐PD Immunotherapy against Metastatic Tumors

Author:

Tan Ya‐Nan12ORCID,Huang Jian‐Dong23,Li Yong‐Peng4,Li Shan‐Shan1,Luo Min1,Luo Jie5,Lee Anne Wing‐Mui15,Fu Li6,Hu Fu‐Qiang7,Guan Xin‐Yuan15ORCID

Affiliation:

1. Department of Clinical Oncology The University of Hong Kong‐Shenzhen Hospital Shenzhen 518053 China

2. Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen 518055 China

3. School of Biomedical Sciences The University of Hong Kong Hong Kong 00852 China

4. Department of Urology The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group) Shenzhen 518000 China

5. Department of Clinical Oncology The University of Hong Kong Hong Kong 00852 China

6. Guangdong Provincial Key Laboratory of Regional Immunity and Diseases Department of Pharmacology and International Cancer Center Shenzhen University Health Science Center Shenzhen 518060 China

7. College of Pharmaceutical Science Zhejiang University Hangzhou 310058 China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Shenzhen Fundamental Research Program

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3